Stryker Rejuvenate and AGB II Settlement Announced

Anapol Weiss Shareholder Thomas Anapol successfully assisted in negotiating a global settlement involving Stryker Rejuvenate and ABG II modular recalled hips, which was announced on November 3. The global settlement is the largest base award with enhancements for metal hip implant settlements.

The Stryker settlement comes on the heels of the Biomet settlement, which was announced in February 2014. Anapol Weiss hip implant lawyer Thomas Anapol was an instrumental leader in both the Stryker and Biomet litigations. Anapol served as Co-Lead counsel in the Biomet litigation and served as one of only four attorneys on the Stryker Negotiations Committee.

The Stryker hip replacement lawsuit settlement will provide plaintiffs with a base award of $300,000 per implant. Recipients who experienced complications during a revision surgery or suffered additional damages may be eligible for additional compensation. Compensation will also be provided to patients who need a revision surgery but are medically unable to undergo the procedure.

Stryker initiated a voluntary recall of the Rejuvenate and ABG II metal on metal hip implants in July 2012 due to the potential risk of complications including metallosis caused by implant corrosion.

Anapol will continue to assist victims of failed metal on metal hip implants. Individuals who have a Stryker metal-on-metal hip and have not yet undergone a revision may still be eligible to file a Stryker hip lawsuit.

Contact Information